Opioid Modulation and Neural Reward Activation in Healthy Adults
Status:
Active, not recruiting
Trial end date:
2022-04-30
Target enrollment:
Participant gender:
Summary
This is a double blind study of the effects of opioid antagonism on the brain's reward
response. The investigators will recruit participants to undergo two scans, one on active
medication and one on placebo. During the scan, the investigators will assess reward.